Risk Factors for PONV in Patients Undergoing Hysteroscopic Surgery

NCT ID: NCT06524752

Last Updated: 2024-07-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1583 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-01-01

Study Completion Date

2024-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was to construct and validate a risk prediction model for PONV in patients undergoing hysteroscopic day-case surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study predicted the risk of postoperative nausea and vomiting in patients undergoing day-case hysteroscopic surgery by constructing and validating a web-based dynamic nomogram.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gynecologic Nursing Postoperative Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Observation group

The patient experience the postoperative nausea or vomiting

The presence of nausea and vomiting within 24 hours after surgery

Intervention Type OTHER

This is a prospective risk prediction model building, thus there is no traditional definition of intervention.

Control group

The patient did not experience postoperative nausea or vomiting

Non-existence of nausea and vomiting within 24 hours after surgery

Intervention Type OTHER

This is a prospective risk prediction model building, thus there is no traditional definition of intervention.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

The presence of nausea and vomiting within 24 hours after surgery

This is a prospective risk prediction model building, thus there is no traditional definition of intervention.

Intervention Type OTHER

Non-existence of nausea and vomiting within 24 hours after surgery

This is a prospective risk prediction model building, thus there is no traditional definition of intervention.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female patients undergoing hysteroscopic day-case surgery and aged 18 years.

Exclusion Criteria

* Patients with intraoperative change of surgical method and unstable postoperative vital signs.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Weifang Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jiang Liu

Research investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Shirong Fang, Researcher

Role: STUDY_DIRECTOR

Weifang People's Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Weifang People's Hospital

Weifang, Shandong, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KYLL20230217-3

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.